There are seven FDA-approved weight loss medications currently available. These medications are safe and effective and have minimal side effects.

Novo Nordisk's liraglutide has been approved for children who are at least 12 years old. However, the drug is now being ...

Wegovy, Zepbound and similar medications all lead to metabolic improvements, but scientists are starting to unpick the ...

The market for weight-loss treatments is expected to see 16 new drugs vying for a slice of the lucrative business currently ...

Looking for successors to the blockbuster GLP-1 obesity drugs, companies like Novo Nordisk and Eli Lilly are testing amylin ...

Eli Lilly has launched a new website-based access programme for some drugs ... access obesity drugs, including WW International (formerly known as Weight Watchers), Found, and Noom, adding to ...

Novo Nordisk's older weight-loss drug Saxenda helped children between the ages of 6 and under 12 reduce their body mass index ...

The widespread use and enormous expense of blockbuster drugs like Wegovy are forcing state governments to make painful ...

Starting price of $149 offers improved accessibility compared to market prices of brand-name medications which can be 8x ...

Morgan Stanley estimated that the global market for obesity drugs could increase by more than ... We've added you to our mailing list.

The wave of new obesity drugs ... the FDA’s shortage list in 2022. They’ve been intermittently unavailable ever since. Shortages are a problem in part because these drugs must be taken consist ...

But does this new version of the drug come with its own costs? Zepbound is the latest drug to join the growing list of anti-obesity medications ... denied access to the essential treatment and ...